tiprankstipranks
Advertisement
Advertisement

Mannatech Delays 10-K Filing Amid Going-Concern Review

Story Highlights
  • Mannatech delayed filing its 2025 Form 10-K after April 1, 2026, using a Form 12b-25 extension.
  • The delay reflects auditor-raised going-concern questions as management reviews repercussions and cost cuts.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Mannatech Delays 10-K Filing Amid Going-Concern Review

Claim 30% Off TipRanks

Mannatech ( (MTEX) ) has issued an update.

On April 1, 2026, Mannatech, Incorporated announced it had filed a Form 12b-25 with the U.S. Securities and Exchange Commission, notifying regulators of a delayed filing of its Form 10-K for the fiscal year ended December 31, 2025. The annual report, originally due March 31, 2026, could not be filed on time without unreasonable effort or expense.

The delay stems from discussions with the company’s independent auditor regarding a potential going-concern issue, prompting management to seek additional time to evaluate repercussions and possible remediation. That review includes consultations with third-party tax advisors and assessment of a cost-reduction plan, and Mannatech expects to submit the 2025 Form 10-K within the 15-day extension period, targeting filing by April 15, 2026.

The most recent analyst rating on (MTEX) stock is a Hold with a $7.50 price target. To see the full list of analyst forecasts on Mannatech stock, see the MTEX Stock Forecast page.

Spark’s Take on MTEX Stock

According to Spark, TipRanks’ AI Analyst, MTEX is a Neutral.

The score is primarily weighed down by weak financial performance: declining revenue, negative margins/ROE, and negative operating and free cash flow. Technicals are only mildly supportive (price above key moving averages but negative MACD), while valuation is pressured by losses reflected in the negative P/E.

To see Spark’s full report on MTEX stock, click here.

More about Mannatech

Mannatech, Incorporated is a global health and wellness company that develops science-backed nutritional products supported by patented technology and a network marketing-driven business opportunity. With operations in more than 25 markets, including a separate cross-border e-commerce platform in China, the company focuses on helping consumers improve their health and well-being while pursuing growth in international markets.

Mannatech targets individuals seeking nutritional supplements and related wellness solutions, leveraging its direct selling model to build a broad base of associates and members. Its business strategy combines product innovation with an incentive-based distribution network, positioning the company within the competitive nutritional and wellness products industry.

Average Trading Volume: 13,868

Technical Sentiment Signal: Sell

Current Market Cap: $12.01M

Find detailed analytics on MTEX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1